1-3 of 3
Vasileios Pardalis, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Serum Soluble Syndecan-1 (ssCD138) Can Contribute to the Discrimination of Lenalidomide Resistant Multiple Myeloma (MM) Patients

Annita Ioanna Gkioka, MD, Aspasia Koudouna, MD, Vasiliki Bartzi, MD, Maria Dimou, MD PhD, Theodoros Iliakis, MD, Aikaterini Bitsani, MD, Vasileios Pardalis, MD, Panayiotis Panayiotidis, MD, Marie-Christine Kyrtsonis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–16.
https://doi.org/10.1182/blood-2020-142006
Published: 2020
Journal Articles

Continuous Clinical Remisssion with High MRD Negativity and High PB and BM MRD Concordance during Venetoclax Monotherapy in R/R CLL Patients

Maria Dimou, MD PhD, Ioannis Anagnostopoulos, MD, Sotiria Kalyva, PhD, Vasileios Pardalis, MD, Athanasios Markopoulos, PhD, Aikaterini Bitsasni, MD, Theodoros Iliakis, MD, Marie-Christine Kyrtsonis, MD, Panayiotis Panayiotidis, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1.
https://doi.org/10.1182/blood-2020-142992
Published: 2020
Journal Articles

Facilitated Subcutaneous Immunoglobulin (fSCIG) Administration in Secondary Immune Deficiency (SID) Due to Hematological Malignancies. Efficacy and Safety Real-World Data from a Single-Center in Greece

Maria Dimou, MD PhD, Vasileios Pardalis, MD PhD, Theodoros Iliakis, MD, Aikaterini Bitsani, MD, Ioannis Grafakos, MD, Sotiria Kalyva, PhD, Athanasios Markopoulos, PhD, Marie-Christine Kyrtsonis, MD PhD, Panayiotis Panayiotidis, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3429.
https://doi.org/10.1182/blood-2019-122834
Published: 2019